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Introduction
Endocrine-disrupting compounds (EDCs) are 
synthetic and naturally occurring chemicals 
that may interfere with endogenous endo-
crine action; particularly, in utero exposure 
or exposure during puberty may produce 
adverse developmental, reproductive, neuro-
logical, and immune effects in both humans 
and wildlife. Exposure to EDCs has been asso-
ciated with reproductive problems, obesity, 
diabetes, cancers, and behavioral and learning 
disorders (reviewed in WHO/UNEP 2013). 
Several substances are thought to cause endo-
crine disruption; most EDCs are classified as 
xenoestrogens whereas others inhibit androgen 
production and function (Meeker 2012). One 
class of EDCs is the environmental phenols, 
which includes bisphenol A (BPA), triclosan 
(TCS), and benzophenone-3 (BP-3). People 
are exposed to environmental phenols through 
industrial pollution, food consumption, 
and the use of personal care and consumer 
products. Parabens are another class of EDCs 
that are prevalent in the environment. These 
substances are used in cosmetics, pharmaceu-
ticals, as antimicrobial preservatives against 
mold, and in food and beverage packaging 
(Calafat et al. 2010).
BPA is considered to have both estrogenic 
and anti-androgenic effects. In a recent review 
of the BPA literature, Peretz et al. (2014) 
concluded that BPA is a reproductive toxicant 
based on findings from experimental and 
epidemiological studies, with strong evidence 
that BPA is an ovarian toxicant in human 
females and animal models, and limited 
evidence of effects on other reproductive 
outcomes in men, women, and animals. In rat 
models, prenatal or perinatal BPA exposure 
has been shown to have adverse effects on the 
male reproductive system including decreased 
epididymal weight and reduced testicular 
sperm counts (Salian et al. 2009a, 2009b). 
Additionally, decreased testosterone (T) levels 
have been observed in rodents exposed to BPA 
during the prepubertal (Takao et al. 1999) 
and pubertal period (Herath et al. 2004). The 
available body of literature suggests that BPA 
is probably a testicular toxicant in animals, 
but the data in humans are more ambiguous 
(Peretz et al. 2014).
TCS has demonstrated anti-androgenic 
action in in vitro studies. Competitive binding 
assays with a recombinant androgen receptor 
(AR) have shown that TCS binds to the 
receptor with relatively high avidity (Gee et al. 
2008). The TCS–AR interaction was also 
confirmed in the T47D human breast cancer 
cell line (Ahn et al. 2008).
The evidence for reproductive effects 
following exposure to BP-3 has been less 
extensively investigated. We identified 
a single panel study of 15 young men (age 
23–29 years) and 17 postmenopausal women 
(age 54–86 years) that compared average levels 
of reproductive hormones after topical applica-
tion of cream containing BP-3 (10% wt/wt) 
to levels after application of a control cream. 
Although some differences were observed, the 
authors concluded these were probably chance 
findings (Janjua et al. 2004). Evidence for 
reproductive effects comes largely from in vitro 
studies that have demonstrated both estrogenic 
and anti-androgenic effects of BP-3 (reviewed 
by Krause et al. 2012). Moreover, some 
experimental animal studies have looked at 
BP-3, but these focus mostly on adult animals 
with few studies looking at early development 
(reviewed by Krause et al. 2012).
In vivo studies of the effect of parabens 
on testosterone levels have produced mixed 
results. Rats and mice exposed in utero to 
parabens showed a significant reduction of 
testosterone levels and mature sperm counts 
(Kang et al. 2002; Oishi 2002a, 2002b), 
whereas other studies found no significant 
changes (Hoberman et al. 2008; Taxvig 
et al. 2008).
Data from the National Health and 
Nutrition Examination Survey (NHANES), 
collected by the Centers for Disease Control 
and Prevention (CDC), have shown wide-
spread exposure to BPA, BP-3, TCS, and 
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Background: Exposure to environmental phenols (e.g., bisphenol A, benzophenone-3, and 
triclosan) and parabens is widespread in the population. Many of these chemicals have been shown 
to have anti-androgenic effects both in vitro and in vivo.
oBjective: We examined the association of bisphenol A (BPA), benzophenone-3 (BP-3), 
triclosan (TCS), and parabens with serum total testosterone (TT) levels in child and adoles-
cent participants (ages 6–19 years) in the National Health and Nutrition Examination Survey 
(NHANES) 2011–2012.
Methods: We performed multivariable linear regression to estimate associations between natural 
log–transformed serum TT and quartiles of urinary BPA, BP-3, TCS, and parabens in male and 
female children (ages 6–11 years) and adolescents (ages 12–19 years).
results: BP-3 and BPA were associated with significantly lower TT in male adolescents, and 
BPA was associated with significantly higher TT in female adolescents. TT was not consistently 
 associated with TCS or total parabens in children or adolescents of either sex.
conclusions: To our knowledge, this is the first study to report an association of both BP-3 
and BPA with serum TT in adolescents. Associations between BPA and TT differed according to 
sex in adolescents, with inverse associations in boys and positive associations in girls. BP-3 was 
associated with significantly lower TT in adolescent boys only. However, because of the limitations 
inherent to the cross-sectional study design, further studies are needed to confirm and elucidate on 
our findings.
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parabens among the U.S. general popula-
tion, including children and adolescents. 
The NHANES 2011–2012 cycle includes 
serum total testosterone (TT) measurements 
in participants ≥ 6 years of age. Because of 
existing concerns about the anti-androgenic 
activity of environmental phenols and 
parabens, we evaluated the relationship of 
TT with urinary levels of BPA, BP-3, TCS, 
and total parabens (∑PAR) among male and 
female children (ages 6–11 years) and adoles-




NHANES is a cross-sectional, nationally 
representative survey of the noninstitutional-
ized civilian population of the United States 
conducted annually by the National Center 
for Health Statistics (NCHS), CDC (Johnson 
et al. 2013). For our study, we used the 
publicly available files for NHANES cycles 
2011–2012. The survey employs a multistage 
stratified probability sample based on selected 
counties, blocks, households, and persons 
within households.
NCHS-trained professionals conducted 
interviews in participants’ homes; extensive 
physical examinations, including blood and 
urine collection, were conducted at mobile 
examination centers. All procedures were 
approved by the NCHS Research Ethics 
Review Board (Continuation of Protocol 
#2011-17; http://www.cdc.gov/nchs/nhanes/
irba98.htm), and all participants provided 
written informed consent. In the 2011–2012 
data set, urinary concentrations of environ-
mental phenols and parabens were measured 
in a randomly selected one-third subsample of 
persons 6 years of age and older by the CDC’s 
National Center for Environmental Health 
(NCEH), Division of Laboratory Sciences 
(DLS), which coordinates the National 
Biomonitoring Program (NBP) to assess 
nutritional status and exposure of the U.S. 
population to environmental chemicals and 
toxic substances. For our analysis, we included 
only those participants who had measure-
ments for urinary phenols and parabens and 
information regarding the covariates included 
in the model (n = 588).
Serum Total Testosterone
Serum samples were shipped to the CDC/
NCEH/DLS, where the serum TT was 
analyzed by isotope dilution liquid chro-
matography tandem mass spectrometry. 
Information regarding reliability, validation, 
and quality control for serum TT are 
described in the NHANES laboratory method 
(http://www.cdc.gov/nchs/data/nhanes/
nhanes_11_12/TST_G_met.pdf). Serum 
TT was natural log–transformed for analyses 
because the distribution of this variable was 
skewed left.
Urinary Biomarkers
Spot urine samples were collected from study 
participants and stored at –20°C; they were 
then analyzed by NCEH/DLS. BPA, BP-3, 
TCS, methyl paraben (MPB), and propyl 
paraben (PPB) were measured by solid phase 
extraction coupled on-line to high perfor-
mance liquid chromatography and tandem 
mass spectrometry. Details of detection and 
measurement of the urinary compounds 
are described in the NHANES laboratory 
methods (http://www.cdc.gov/nchs/nhanes/
nhanes2011-2012/lab_methods_11_12.
htm). The reported results for all assays meet 
the NCEH/DLS quality control and quality 
assurance performance criteria for accuracy 
and precision (NCHS 2013). The limits of 
detection (LOD) were 0.4 ng/mL for BPA, 
0.4 ng/mL for BP-3, 2.3 ng/mL for TCS, 
1.0 ng/mL for MPB, and 0.2 ng/mL for PPB. 
Urinary concentrations of the compounds 
below the level of detection were assigned the 
limit of detection divided by the square root 
of 2, as recommended by NHANES (NCHS 
2013). To account for variation in dilution in 
spot urinary samples, we adjusted for urinary 
creatinine by including it as a model covariate 
(Barr et al. 2005; Ikeda et al. 2003). The 
parabens (∑PAR) were considered together 
as a sum of total parabens (MPB and PPB), 
calculated by adding the concentration of each 
individual metabolite (Buttke et al. 2012). 
There were no significant correlations between 
the urinary compounds (data not shown), 
except between urinary ∑PAR and TCS or 
BPA as indicated by the Pearson correlation 
coefficients (r = 0.18, p < 0.0001; and r = 0.08 
p < 0.04, respectively).
Covariates
All models were adjusted for the following 
a priori covariates: age, race/ethnicity, 
urinary creatinine, poverty income ratio 
(PIR), obesity, season of collection, time of 
venipuncture, total serum cholesterol, serum 
cotinine as a biomarker of exposure to envi-
ronmental tobacco smoke, and physical 
activity (only for male and female adoles-
cents). Race/ethnicity was categorized as non-
Hispanic white, non-Hispanic black, Hispanic 
(Mexican American and other Hispanic), and 
other. PIR is a measure of socioeconomic 
status and represents the calculated ratio of 
household income to the poverty threshold 
after accounting for inflation and family size; 
it was entered as a continuous variable. Time 
of venipuncture is found in the NHANES 
Fasting Questionnaire File and was clas-
sified as morning, afternoon, or evening 
sessions. Season of collection was obtained 
from the NHANES demographic data 
pertaining to the 6 month time period when 
the examination occurred; this was either 
1 November–30 April or 1 May–31 October. 
We included this covariate because of the 
differences in use of these products (i.e., use 
of sunscreen with BP-3 and parabens increases 
during the summer). Moreover, levels of 
TT in men have a wide range of variation 
due to diurnal, weekly, and seasonal varia-
tions (Brambilla et al. 2009; Cunningham 
and Toma 2011). Children and adolescents 
were classified as underweight, normal weight, 
overweight, or obese according to age and sex, 
as defined by NHANES (Body Measures File; 
http://wwwn.cdc.gov/Nchs/Nhanes/2011-
2012/BMX_G.htm). For our analyses, we 
combined underweight and normal weight 
as one category. Serum cotinine and urinary 
creatinine were natural log–transformed. 
Information on recreational physical activity 
was available for adolescents only; partici-
pants were asked whether they engaged in 
regular moderate and/or vigorous recreational 
 activities (categorized as yes or no).
In addition to models adjusted for the 
covariates indicated above, we ran a second 
model for each exposure that was adjusted 
for urinary concentrations of the other three 
exposures, which were modeled as natural 
log–transformed continuous variables.
Statistical Methods
All analyses were performed using the weight 
from the urinary phenols and parabens 
subsample, as recommended by NCHS, to 
account for the complex sampling design and 
nonresponse of NHANES; all analyses were 
performed according to NHANES guidelines 
(Johnson et al. 2013). SAS 9.3 (SAS Institute 
Inc., Cary, NC) was used for all statistical 
analyses, and SAS-Callable SUDAAN 10 
(Research Triangle Institute, Research 
Triangle Park, NC) was used to account 
for the NHANES complex sample design. 
p-Values were presented at the significance 
level < 0.05.
Analyses were conducted for male children 
(6–11 years), male adolescents (12–19 years), 
female children (6–11 years), and female 
adolescents (12–19 years). We used multi-
variable linear regression to calculate adjusted 
β coefficients for the associations between 
natural log–transformed TT and urinary 
phenol and paraben levels among the partici-
pants. Urinary BPA, BP-3, TCS, and ∑PAR 
were categorized according to quartiles defined 
for each population subgroup.
Because our dependent variable, TT, was 
log-transformed, the results were retrans-
formed by exponentiation of the β coefficients 
and presented as percent differences estimated 
by comparing each of the upper three quartiles 
to the lowest quartile. Statistical tests for linear 
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trends were conducted by modeling quartiles 
as an ordinal variable using integer values.
Results
Table 1 presents the characteristics of the study 
population by age and sex. The geometric 
mean (GM) serum TT levels for male children, 
male adolescents, female children, and female 
adolescents were 3.75 ng/dL, 276.07 ng/dL, 
5.80 ng/dL, and 22.78 ng/dL, respectively 
(Table 1). There was a statistically significant 
difference in mean urinary TCS and ∑PAR 
levels between female children and female 
adolescents (p < 0.05) (data not shown). There 
were no other statistically significant differ-
ences in urinary compound levels between 
age- and sex-specific groups (e.g., differences in 
mean urinary levels between male children and 
adolescents, differences in mean urinary levels 
between male and female adolescents).
Benzophenone-3 (Table 2). Male adoles-
cents in the 3rd and 4th quartiles of BP-3 
had significantly lower TT [–38.74%; 95% 
confidence interval (CI): –58.52%, –10.42%; 
and –36.87%; 95% CI: –59.34%, –1.98%, 
respectively, based on model 1] than males in 
the lowest quartile. Although the association 
was strongest for the 3rd quartile, the overall 
trend was significant (p-trend = 0.01). This 
pattern of associations persisted following 
adjustment for BPA, TCS, and ∑PAR 
(model 2). In female adolescents, TT was 
significantly higher for girls in the second 
versus first quartile of BP-3 exposure, but 
positive associations were closer to the null 
and nonsignificant for the 3rd and 4th quar-
tiles of exposure (p-trend 0.14). Associations 
were similar after adjustment for BPA, TCS, 
and ∑PAR, but no longer significant for 
quartile 2. There were no significant associa-
tions between TT and BP-3 in male or female 
children, and no evidence of consistent trends 
with increasing quartiles of exposure.
Bisphenol A (Table 3). Mean TT was 
lower for all quartiles of exposure above 
the reference level in male adolescents 
(p-trend = 0.01), with significant associa-
tions for the 2nd and 4th quartiles of BPA 
(–49.34%; 95% CI: –70.18%, –13.06%; 
and –53.70%; 95% CI: –70.77%, –26.66% 
respectively, model 1). By contrast, TT was 
positively associated with BPA exposure in 
female adolescents, with a monotonic increase 
in mean TT with increasing quartiles of 
exposure (p-trend = 0.01) and significantly 
higher TT for the 4th quartile (53.73%; 
95% CI: 9.42%, 113.83%) compared with 
the lowest quartile. BPA did not appear to be 
associated with TT in male or female children. 
Estimated associations and overall patterns 
were similar for all population subgroups after 
adjustment for BP-3, TCS, and ∑PAR.
Triclosan (Table 4). Mean TT was lower 
for all quartiles of TCS compared with the 
lowest quartile in all population subgroups, 
and trend p-values were significant for male 
children and adolescents (p-trend = 0.02 and 
0.04, respectively). However, model 1 quartile-
specific decreases were significant only for the 
3rd quartile in male adolescents and in female 
children, and mean values were closest to the 
null for the highest quartile in male children 
and adolescents and in female children, 
whereas all associations were close to the null 
for female adolescents. Associations were 
generally consistent with model 1 estimates 
after adjustment for BP-3, BPA, and ∑PAR, 
though the negative association with quartile 3 
was significant only in female children, and the 
p-trend was significant only for male children.
Parabens (Table 5). There were no statis-
tically significant associations between TT 
and ∑PAR in any subgroup before or after 
adjustment for BP-3, BPA, and TCS, and no 
evidence of consistent trends with increasing 
quartiles of exposure.
Discussion
To our knowledge, this is the first study to 
investigate the associations of BPA, BP-3, 
TCS, and ∑PAR with serum TT in children 
and adolescents. In this cross-sectional 
analysis of data from NHANES 2011–2012, 
both urinary BPA and urinary BP-3 levels 
were inversely associated with serum TT in 
male adolescents; conversely, higher levels of 
BPA were associated with higher serum TT 
in female adolescents. No significant asso-
ciations were observed in children (male or 
female). Overall, there was little evidence of 
associations between TCS and TT, and no 
significant associations with ∑PAR in any of 
the four population subgroups.
Associations between BPA levels and TT 
differed between male and female adolescents, 
with an inverse association in males and a 
positive association in females. As reviewed by 
Gore et al. (2015), several animal studies have 
focused solely on the associations of BPA with 
serum testosterone in male animals; these 
studies have consistently reported decreased 
serum testosterone levels in these animals. 
However, other studies have looked at both 
male and female animals, and several of these 
studies have reported sex differences in testos-
terone levels following BPA exposure. Chen F 
et al. (2014) reported significantly lower 
serum testosterone in male rats exposed to 
BPA than in controls, whereas BPA-exposed 
female rats had nonsignificantly higher 
serum testosterone. Fernández et al. (2010) 
reported increased serum testosterone and 











n 134 161 142 157
Urinary bisphenol A (ng/mL) [GM (SE)] 1.74 (0.26) 1.94 (0.29) 1.40 (0.17) 1.49 (0.21)
Urinary benzophenone-3 (ng/mL) [GM (SE)] 15.57 (4.61) 20.03 (5.69) 18.31 (3.96) 35.59 (14.40)
Urinary triclosan (ng/mL) [GM (SE)] 8.79 (1.80) 8.55 (1.67) 6.30 (0.72) 12.27 (3.05)
Urinary total parabens (ng/mL) [GM (SE)] 15.07 (4.19) 18.51 (4.15) 29.51 (6.58) 63.75 (17.23)
Age (years) [GM (SE)] 8.39 (0.20) 15.50 (0.19) 8.76 (0.15) 15.20 (0.17)
Serum total testosterone (ng/dL) [GM (SE)] 3.75 (0.60) 276.07 (27.71) 5.80 (0.54) 22.78 (0.73)
Serum cotinine (ng/mL) [GM (SE)] 0.06 (0.01) 0.12 (0.02) 0.05 (0.01) 0.14 (0.05)
Urinary creatinine (mg/dL) [GM (SE)] 71.18 (6.16) 112.65 (10.23) 68.09 (5.42) 98.87 (11.42)
Total cholesterol (mg/dL) [GM (SE)] 156.25 (2.27) 148.93 (2.61) 156.42 (3.33) 159.16 (5.82)
Ratio family income to poverty [GM (SE)] 1.65 (0.09) 1.73 (0.25) 1.76 (0.18) 1.73 (0.22)
Obesitya
Normal/underweight [% (SE)] 93.83 (1.93) 59.12 (3.11) 86.16 (3.16) 64.21 (8.17)
Overweight [% (SE)] 5.14 (2.31) 23.40 (3.64) 9.07 (3.85) 16.25 (4.16)
Obese [% (SE)] 1.03 (0.77) 17.49 (4.58) 4.78 (1.85) 19.54 (6.14)
Race/ethnicity
White (non-Hispanic) [% (SE)] 54.45 (5.59) 55.06 (4.75) 55.13 (7.84) 55.46 (6.60)
Non-Hispanic black [% (SE)] 15.40 (1.97) 15.73 (4.07) 12.21 (3.17) 15.44 (5.05)
Hispanic [% (SE)] 21.78 (5.12) 22.21 (3.98) 25.10 (5.25) 21.69 (4.07)
Other [% (SE)] 7.37 (2.49) 7.00 (2.45) 7.57 (2.12) 7.41 (1.44)
Session time of venipuncture
Morning 42.20 (5.42) 51.94 (6.77) 53.74 (4.01) 42.36 (4.89)
Afternoon 31.88 (3.96) 29.45 (4.98) 30.16 (4.51) 36.83 (4.64)
Evening 25.92 (4.75) 18.61 (5.37) 16.10 (3.06) 20.81 (5.11)
Six month time period when the examination was performed
1 November through 30 April [% (SE)] 52.60 (7.30) 47.64 (9.29) 48.08 (6.93) 40.15 (7.91)
1 May through 31 October [% (SE)] 47.40 (7.30) 52.36 (9.29) 51.92 (6.93) 59.85 (7.91)
Physical activityb
Yes [% (SE)] 90.23 (3.05) 71.43 (4.21)
No [% (SE)] 9.77 (3.05) 28.57 (4.21)
aChildren and adolescents were classified as underweight, normal weight, overweight, or obese according to age and 
sex, as defined by NHANES (http://wwwn.cdc.gov/Nchs/Nhanes/2011-2012/BMX_G.htm).
bInformation on recreational physical activity was available for adolescents only; participants were asked whether they 
engaged in regular moderate and/or vigorous recreational activities (categorized as yes or no).
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serum estradiol levels in female rats exposed 
postnatally to BPA. Furthermore, Xi et al. 
(2011) reported that the expression of several 
genes related to the hypothalamic–pituitary–
gonadal (HPG) axis was increased in both 
male and female mice pups following BPA 
exposure; several hormonal changes including 
decreased testosterone synthesis in male pups 
and enhanced aromatase expression levels 
and estrogen synthesis in female pups were 
contemporarily observed, suggesting that the 
changes in gene expression may have affected 
downstream hormonal levels.
Levels of serum TT in men have a wide 
range of variation due to diurnal, weekly, 
and seasonal variations, episodic secretion, 
and glucose ingestion (Brambilla et al. 2009; 
Cunningham and Toma 2011). Diurnal 
variation results in peak serum TT levels in 
the early morning followed by a progressive 
decline to the lowest levels in the evening, 
which may be as little as 15% lower than 
peak morning levels, and as much as 50% 
lower in younger males (Paduch et al. 2014). 
Testosterone circulates in the body either 
bound to sex hormone–binding globulin 
(SHBG), albumin, or corticosteroid binding 
globulin (CBG), or in an unbound form 
(free). SHBG-bound T represents approxi-
mately 44% of TT and is tightly bound and 
unavailable to cells. Albumin-bound T and 
CBG-bound T represent approximately 50% 
and 4% of TT, and for both, T is weakly 
bound and dissociates rapidly. Free testos-
terone (FT) represents about 2–3% of TT 
(De Ronde et al. 2006). The term “bioavail-
able” T refers to the sum of the CBG-bound, 
albumin-bound, and free components, thus 
representing the T fraction available to cells. 
In the present study, we evaluated TT, which 
includes both bioavailable and bound forms.
Few epidemiological  studies have 
examined relationships between BPA and 
sex hormones, and study populations have 
been limited to adults. Our finding of a 
positive association of BPA and TT in female 
adolescents is in agreement with the findings 
reported by Takeuchi and Tsutsumi (2002) 
and Takeuchi et al. (2004). Takeuchi and 
Tsutsumi (2002) investigated the relation-
ship between BPA exposure and hormone 
levels in men (n = 11) and women (n = 30), 
showing positive correlations between serum 
BPA concentrations with TT and FT levels 
in both sexes. A significant, positive rela-
tionship was reported between circulating 
androgen concentrations and BPA exposure 
in a small study of 26 normal women and 
47 women with ovarian dysfunction 
(Takeuchi et al. 2004). The inverse associa-
tion of BPA and serum TT that we found 
in male adolescents may be consistent with 
epidemiological studies conducted in male 
adults (Meeker et al. 2010; Mendiola et al. 
2010; Zhou et al. 2013). Recently, Zhou 
et al. (2013), in a cross-sectional study of 
290 men with or without BPA exposure in 
the workplace, found that serum BPA was 
significantly associated with decreased FT 
levels, decreased free androgen index (FAI), 
and increased SHBG levels. Mendiola et al. 
(2010) examined urinary BPA and serum 
hormones in fertile men (n = 360) and found 
a significant inverse association between 
urinary BPA concentration and FAI concen-
tration levels as well as a significant positive 
Table 2. Percent differences (95% CI) in serum total testosterone by quartiles of BP-3 exposure, National 
Health and Nutrition Examination Survey, 2011–2012.
BP-3 exposure Model 1a Model 2b
Male children
Q1: ≤ 3.5 ng/mL Reference Reference
Q2: 3.6–8.8 ng/mL –1.98 (–51.81, 97.39) 7.25 (–46.74, 115.98)
Q3: 8.9–71.1 ng/mL 27.12 (–20.55, 105.44) 31.00 (–25.17, 129.33)
Q4: > 71.7 ng/mL –1.98 (–44.57, 73.33) 4.08 (–40.55, 82.21)
p-Trendc 0.53 0.70
Male adolescents
Q1: ≤ 4.0 ng/mL Reference Reference
Q2: 4.1–15.9 ng/mL –7.69 (–43.45, 50.68) 1.01 (–34.30, 55.27)
Q3: 16.0–48.7 ng/mL –38.74 (–58.52, –10.42) –32.97 (–54.16, –1.98)
Q4: > 48.7 ng/mL –36.87 (–59.34, –1.98) –32.97 (–54.16, –0.50)
p-Trendc 0.01 0.04
Female children
Q1: ≤ 6.6 ng/mL Reference Reference
Q2: 6.7–13.9 ng/mL 10.52 (–19.75, 50.68) 7.25 (–31.61, 68.20)
Q3: 14.0–58.5 ng/mL 5.13 (–20.55, 39.10) –0.50 (–50.84, 101.38)
Q4: > 58.6 ng/mL 20.92 (–28.82, 105.44) 10.52 (–68.65, 293.54)
p-Trendc 0.87 0.91
Female adolescents
Q1: ≤ 8.6 ng/mL Reference Reference
Q2: 8.7–23.7 ng/mL 20.92 (3.05, 43.33) 17.35 (–1.00, 39.10)
Q3: 23.8–164.0 ng/mL 10.52 (–18.13, 49.18) 12.75 (–16.47, 50.68)
Q4: > 164.0 ng/mL 11.63 (–23.66, 64.87) 16.18 (–21.34, 71.60)
p-Trendc 0.14 0.27
aAdjusted for age, race/ethnicity, serum cotinine, urinary creatinine, total cholesterol, income, obesity, season of collec-
tion, time of venipuncture, and physical activity (for adolescents only).
bAdjusted for model 1 covariates plus natural log–transformed BPA, TCS, and ∑PAR.
cp-Value for exposure quartiles modeled as an ordinal variable using integer values.
Table 3. Percent differences (95% CI) in serum total testosterone by quartiles of BPA exposure, National 
Health and Nutrition Examination Survey, 2011–2012.
BPA exposure Model 1a Model 2b
Male children
Q1: ≤ 0.8 ng/mL Reference Reference
Q2: 0.9–1.5 ng/mL 16.18 (–44.01, 141.09) 9.42 (–46.74, 124.79)
Q3: 1.6–3.3 ng/mL –14.79 (–62.84, 95.42) –18.94 (–66.38, 93.48)
Q4: > 3.3 ng/mL –10.42 (–41.14, 37.71) –22.12 (–55.07, 34.99)
p-Trendc 0.27 0.19
Male adolescents
Q1: ≤ 0.9 ng/mL Reference Reference
Q2: 1.0–2.0 ng/mL –49.34 (–70.18, –13.06) –50.84 (–71.92, –13.93)
Q3: 2.1–3.7 ng/mL –36.87 (–62.47, 6.18) –38.12 (–63.21, 4.08)
Q4: > 3.7 ng/mL –53.70 (–70.77, –26.66) –52.29 (–71.35, –20.55)
p-Trendc 0.01 0.02
Female children
Q1: ≤ 0.7 ng/mL Reference Reference
Q2: 0.8–1.4 ng/mL 8.33 (–28.82, 64.87) 18.53 (–36.24, 118.15)
Q3: 1.5–2.8 ng/mL 8.33 (–30.93, 69.89) 19.72 (–42.88, 153.45)
Q4: > 2.8 ng/ mL 20.92 (–35.60, 127.05) 40.49 (–56.83, 352.67)
p-Trendc 0.86 0.94
Female adolescents
Q1: ≤ 0.7 ng/mL Reference Reference
Q2: 0.8–1.5 ng/mL 24.61 (–7.69, 69.89) 27.21 (–4.88, 71.60)
Q3: 1.6–3.2 ng/mL 39.10 (–4.88, 103.40) 36.34 (–6.76, 101.38)
Q4: > 3.2 ng/mL 53.73 (9.42, 113.83) 53.73 (12.75, 109.59)
p-Trendc 0.01 < 0.01
aAdjusted for age, race/ethnicity, serum cotinine, urinary creatinine, total cholesterol, income, obesity, season of collec-
tion, time of venipuncture, and physical activity (for adolescents only).
bAdjusted for model 1 covariates plus natural log–transformed BP-3, TCS, and ∑PAR.
cp-Value for exposure quartiles modeled as an ordinal variable using integer values.
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association between BPA and SHBG levels. 
In a subset of 167 men attending an infer-
tility clinic, Meeker et al. (2010) found that 
urinary BPA concentrations were inversely 
associated with serum inhibin B, FAI, and 
estradiol/testosterone index (a marker of 
aromatase activity). Additionally, they found 
a positive association between urinary BPA 
with both follicle-stimulating hormone 
(FSH) and FSH/inhibin B ratio (a marker 
of Sertoli cell function). Conversely, several 
studies reported a positive association of BPA 
and testosterone in male adults (Galloway 
et al. 2010; Hanaoka et al. 2002; Takeuchi 
and Tsutsumi 2002). Hanaoka et al. (2002) 
reported that urinary concentrations of 
BPA were significantly higher in 42 exposed 
workers than in matched controls (n = 42) and 
that urinary BPA level was inversely correlated 
with serum FSH concentrations (Hanaoka 
et al. 2002). Galloway et al. (2010) found 
that higher daily BPA excretion was associated 
with a higher TT concentration in 307 men 
from the InCHIANTI study among adult 
males in Italy.
To our knowledge, the only epide-
miological study investigating the associa-
tion of urinary BP-3 with sex hormones was 
conducted by Janjua and colleagues (2004). 
The authors reported that the mean serum 
testosterone concentration in 15 young men 
was significantly lower 4 hr after they were 
treated with cream containing BP-3 compared 
with levels 4 hr after a control cream was 
applied. However, there was no significant 
difference 24 hr after application of the BP-3 
or control cream. Testosterone levels were 
also lower in 17 postmenopausal women after 
application of the BP-3 versus control cream, 
but because testosterone levels were lower 
before and after the BP-3 cream was applied, 
the authors attributed the finding to chance.
The present study has several important 
limitations. First, the cross-sectional nature 
of this study limits the inferences that can be 
made based on the results. Moreover, 12- to 
19-year-old boys and girls classified as adoles-
cents may have included a mix of children 
who were pre- and postpubescent. Recently, 
Lopez-Espinosa et al. (2011), in their study 
of the association between sex hormones and 
perfluorocarbon compounds, considered TT 
> 50 ng/dL to be a cutoff for reaching puberty 
in male children/adolescents. Based on this 
cutoff, we found that at age 10 and at age 11 
years, 7.59% and 29.17% of male participants 
had reached puberty, respectively; no male 
children < 10 years of age had reached puberty 
based on this cutoff point. On the other 
hand, for those 12 years and 13 years of age, 
67.16% and 83.56% had reached puberty, 
respectively; all male adolescents > 13 years of 
age had serum TT levels higher than 50 ng/dL 
(data not shown). Therefore, the age cutoff 
used in this study to classify boys as children 
or adolescents seems appropriate.
Recent findings from experimental 
studies suggest that BPA may affect aroma-
tase activity, which might subsequently lead 
to changes in concentrations of FT, FAI, 
or estradiol (E2), and in the E2/T ratio. 
For example, Castro et al. (2013) reported 
increased aromatase activity in adult male 
Wistar rats exposed to BPA, concurrent 
with decreased testosterone and increased 
E2 and E2/T ratio levels. E2 and aromatase 
Table 4. Percent differences (95% CI) in serum total testosterone by quartiles of TCS exposure, National 
Health and Nutrition Examination Survey, 2011–2012.
TCS exposure Model 1a Model 2b
Male children
Q1: ≤ 2.5 ng/mL Reference Reference
Q2: 2.6–6.1 ng/mL –34.95 (–72.47, 53.73) –37.50 (–72.75, 41.91)
Q3: 6.2–18.1 ng/mL –15.63 (–63.58, 93.48) –17.30 (–62.09, 80.40)
Q4: > 8.1 ng/mL –10.42 (–52.29, 158.57) –16.18 (–51.32, 177.32)
p-Trendc 0.02 0.01
Male adolescents
Q1: ≤ 2.6 ng/mL Reference Reference
Q2: 2.7–5.7 ng/mL –32.97 (–63.94, 23.37) –24.42 (–55.51, 28.40)
Q3: 5.8–19.0 ng/mL –39.95 (–61.71, –5.82) –36.87 (–60.94, 2.02)
Q4: > 19.0 ng/mL –10.42 (–41.73, 39.10) –9.52 (–39.35, 33.64)
p-Trendc 0.04 0.08
Female children
Q1: ≤ 2.3 ng/mL Reference Reference
Q2: 2.4–3.9 ng/mL –11.31 (–28.82, 11.63) 22.14 (–34.30, 2.02)
Q3: 4.0–15.3 ng/mL –32.97 (–52.29, –4.88) –35.60 (–58.10, –1.00)
Q4: > 15.3 ng/ mL –9.52 (–36.87, 28.40) –17.30 (–56.83, 60.00)
p-Trendc 0.11 0.06
Female adolescents
Q1: ≤ 2.5 ng/mL Reference Reference
Q2: 2.6–7.3 ng/mL –2.96 (–24.42, 24.61) –3.92 (–27.39, 25.86)
Q3: 7.4–31.6 ng/mL –4.88 (–30.93, 32.31) –12.19 (–37.50, 24.61)
Q4: > 31.6 ng/mL –11.31 (–34.30, 20.92) –10.42 (–34.30, 22.14)
p-Trendc 0.69 0.88
aAdjusted for age, race/ethnicity, serum cotinine, urinary creatinine, total cholesterol, income, obesity, season of collec-
tion, time of venipuncture, and physical activity (for adolescents only).
bAdjusted for model 1 covariates plus natural log–transformed BP-3, BPA, and ∑PAR.
cp-Value for exposure quartiles modeled as an ordinal variable using integer values.
Table 5. Percent differences (95% CI) in serum total testosterone by quartiles of ∑PAR exposure, 
National Health and Nutrition Examination Survey, 2011–2012.
∑PAR exposure Model 1a Model 2b
Male children
Q1: ≤ 4.4 ng/mL Reference Reference
Q2: 4.5–10.1 ng/mL 44.77 (–21.34, 169.12) 43.33 (–17.30, 148.43)
Q3: 10.2–40.0 ng/mL –15.63 (–46.74, 32.31) –14.79 (–42.88, 28.40)
Q4: > 40.0 ng/mL 10.52 (–37.50, 95.42) 16.18 (–36.24, 113.83)
p-Trendc 0.22 0.29
Male adolescents
Q1: ≤ 4.9 ng/mL Reference Reference
Q2: 5.0–10.2 ng/mL –22.12 (–55.96, 39.10) –13.06 (–51.36, 53.73)
Q3: 10.3–61.5 ng/mL –16.47 (–45.66, 27.12) –3.92 (–32.29, 36.34)
Q4: > 61.5 ng/mL –23.66 (–51.32, 18.53) –14.79 (–48.31, 41.91)
p-Trendc 0.49 0.82
Female children
Q1: ≤ 11.3 ng/mL Reference Reference
Q2: 11.4–22.7 ng/mL 13.88 (–12.19, 47.70) 19.72 (–12.19, 63.23)
Q3: 22.8–76.8 ng/mL 12.55 (–21.34, 50.68) 18.53 (–13.06, 63.23)
Q4: > 76.8 ng/ mL 31.00 (–4.88, 82.21) 53.73 (–18.13, 191.54)
p-Trendc 0.39 0.11
Female adolescents
Q1: ≤ 15.5 ng/mL Reference Reference
Q2: 15.6–66.6 ng/mL –8.61 (–34.95, 29.69) –5.82 (–32.29, 31.00)
Q3: 66.7–297.9 ng/mL –21.34 (–43.45, 8.33) –24.42 (–44.57, 3.05)
Q4: > 297.9 ng/mL 3.05 (–29.53, 52.20) 4.08 (–25.92, 47.70)
p-Trendc 0.11 0.02
aAdjusted for age, race/ethnicity, serum cotinine, urinary creatinine, total cholesterol, income, obesity, season of collec-
tion, time of venipuncture, and physical activity (for adolescents only).
bAdjusted for model 1 covariates plus natural log–transformed BP-3, BPA, and TCS.
cp-Value for exposure quartiles modeled as an ordinal variable using integer values.
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activity increased in the urogenital sinus of 
fetal mice after maternal exposure to low-dose 
BPA (Arase et al. 2011). Furthermore, 
BPA-induced aromatase activation was 
reported by Kim et al. (2010) in rat testic-
ular Leydig cells and by Nativelle-Serpentini 
et al. (2003) in human placenta JEG-3 cells 
following pre-incubation times ranging from 
10 min to 6 hr, whereas Chen S et al. (2014) 
showed that BPA did not induce aromatase 
activation in human MCF-7 breast cancer 
cell lines, instead functioning as an estrogen 
receptor agonist. Conversely, other in vitro 
studies have reported aromatase inhibition 
by BPA (Benachour et al. 2007; Bonefeld-
Jørgensen et al. 2007). These hormones were 
not measured for the 2011–2012 NHANES 
survey, so we were unable to investigate 
whether there was any association with BPA in 
the population of interest.
The use of a single spot measure-
ment of serum TT is also a limitation given 
cyclical variation in hormone levels. We 
adjusted for the time of day (session) when 
the sample was collected (morning, after-
noon, or evening) and for the season 
of collection (1 November–30 April or 
1 May–31 October), but residual confounding 
is possible if the timing or season of sample 
collection was associated with exposure levels. 
Another important limitation is the use 
of single spot urinary phenols and parabens 
measurements. Because these chemicals are 
short lived in the body, a biomarker of longer-
term exposure would have been better. It 
has been shown that a single sample of BPA 
may be predictive of long-term exposure; 
Mahalingaiah et al. (2008) reported that study 
participants were correctly classified as being 
in the highest tertile of BPA exposure about 
two-thirds of the time, based on data from 
31 men and women attending an infertility 
clinic. However, overall, the use of the single 
spot measurements of exposure is a limitation 
of this study. There may also have been other 
confounding factors that we did not control 
for in our analyses, including exposure to other 
environmental chemicals that are potentially 
anti-androgenic, such as phthalates (Meeker 
and Ferguson 2014).
Conclusion
In conclusion, urinary levels of BP-3 and 
BPA were associated with lower levels of 
serum testosterone in male adolescents (age 
12–19 years), while BPA was positively asso-
ciated with serum TT in female adolescents 
in NHANES 2011–2012. These findings 
are of interest due to the pervasiveness of 
these chemicals in our environment and the 
potential impact that altered reproductive 
hormones, such as testosterone, can have on 
the development and overall health of children 
and adolescents. Because of the limitations of 
this study, our results should be interpreted 
with caution. However, our results support 
the need for future studies to confirm our 
findings and investigate potential mechanisms 
for differences between males and females, 
including longitudinal observational studies 
of associations between long-term exposures 
to EDCs and endocrine and reproductive 
hormone levels, and experimental animal 
and in vitro studies of the effects of low-dose 
 environmentally relevant exposures.
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